Literature DB >> 9716728

Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain.

M L Liou1, C Y Hsu.   

Abstract

Japanese encephalitis (JE) virus principally infects neuron systems of animals and causes severe encephalitis. The mechanism by which the virus enters the central nervous system (CNS) from the circulatory system remains elusive. In this study, electron-microscopic techniques have been used to determine these sequential events in the suckling mouse brain. The results indicate that (1) endocytosis is employed when JE virus is transported across the cerebral blood vessels (CBV) and breaches the blood-brain barrier (BBB). (2) Uncoated vesicles, which may be caveolae, and coated vesicles are involved in the endocytic and transcytotic vesicles of capillary endothelium and pericytes. (3) The JE virus is transported in endocytic vesicles across the endothelial cells and pericytes. (4) Endocytosis and transportation of JE virus in pericytes seems to be the same as that in endothelial cells. (5) The interaction of the viral envelope and cell membrane of endothelial cells and pericytes plays an important role in the endocytosis. This study elucidates the infectious processes of JE virus entering the CNS from the circulatory system in the mouse brain.

Entities:  

Mesh:

Year:  1998        PMID: 9716728     DOI: 10.1007/s004410051130

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  36 in total

1.  Japanese encephalitis.

Authors:  T Solomon; N M Dung; R Kneen; M Gainsborough; D W Vaughn; V T Khanh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

Review 2.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

Review 3.  Microbes' roadmap to neurons.

Authors:  Krister Kristensson
Journal:  Nat Rev Neurosci       Date:  2011-05-18       Impact factor: 34.870

4.  Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice.

Authors:  Rosa M Licon Luna; Eva Lee; Arno Müllbacher; Robert V Blanden; Rod Langman; Mario Lobigs
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence.

Authors:  Mélissanne de Wispelaere; Marie-Pascale Frenkiel; Philippe Desprès
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

6.  Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism.

Authors:  Manjula Kalia; Renu Khasa; Manish Sharma; Minu Nain; Sudhanshu Vrati
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

7.  Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.

Authors:  Fang Li; Yueyun Wang; Lan Yu; Shengbo Cao; Ke Wang; Jiaolong Yuan; Chong Wang; Kunlun Wang; Min Cui; Zhen F Fu
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

Review 8.  West Nile virus and its emergence in the United States of America.

Authors:  Kristy O Murray; Eva Mertens; Philippe Despres
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

9.  Infection of pericytes in vitro by Japanese encephalitis virus disrupts the integrity of the endothelial barrier.

Authors:  Chun-Jung Chen; Yen-Chuan Ou; Jian-Ri Li; Cheng-Yi Chang; Hung-Chuan Pan; Ching-Yi Lai; Su-Lan Liao; Shue-Ling Raung; Chen-Jung Chang
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.

Authors:  Penghua Wang; Jianfeng Dai; Fengwei Bai; Kok-Fai Kong; Susan J Wong; Ruth R Montgomery; Joseph A Madri; Erol Fikrig
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.